STOP LOCATION said on DATE that it was close to completing an agreement with ORGANIZATION that would almost halve the price it pays for Kaletra a drug used to treat MISC patients STOP  The pending agreement which would lower the drug 's price to MONEY a pill from MONEY comes after DURATION of negotiations and stern warnings from LOCATION that it would disregard PERSON 's patent and make a generic version of Kaletra domestically if the company did not lower the price to a level it deemed affordable STOP 